Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Cell & Gene Therapy

Stem cell research and commercialization in China...

CHMP Recommends Approval of Legend’s CAR-T as Second-Line Multiple Myeloma Therapy

Wuhan iRegene Therapeutics Starts China Trial of iPSC Cell Therapy for Parkinson’s

Gracell Approved for US Trial of FasTCAR in Early Multiple Myeloma

Vesicure Announces Positive Early Results of Exosome Technology for siRNA Delivery

Refreshgene’s siRNA Therapy Enables Children with Genetic Deafness to Hear

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital